Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC
Chenhe Yi, Lirong Chen, Zhifei Lin, Lu Liu, Weiqing Shao, Rui Zhang, Jing Lin, Jubo Zhang, Wenwei Zhu, Huliang Jia, Lunxiu Qin, Lu Lu, Jinhong Chen – 25 May 2021